This report aims to provide a comprehensive presentation of the global market for Recombinant Vaccines, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Vaccines.

The Recombinant Vaccines market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Recombinant Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Vaccines manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Recombinant Vaccines market size in 2022 is 13320.00 million US dollars, and it is expected to be 29281.04 million US dollars by 2029, with a compound annual growth rate of 11.91% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Recombinant Vaccines market include GSK plc, Pfizer Inc., Sanofi, Walvax Biotechnology Co., Ltd. (Walvax), and Dynavax Technologies Corporation. The share of the top 3 players in the Recombinant Vaccines market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of Recombinant Vaccines market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Hepatitis B accounted for XX% of Recombinant Vaccines market in 2022. Rotavirus share of XX%.
Paediatrics accounted for XX% of the Recombinant Vaccines market in 2022. Adults accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Recombinant Vaccines industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Recombinant Vaccines market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and expansion in recent years.
Chapters 4-6: Segmented the global Recombinant Vaccines market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, South America and Middle East & Africa Recombinant Vaccines market country segmentation data and SWOT analysis.
Chapter 12: Analyzes the Recombinant Vaccines industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: Analyzes the Recombinant Vaccines manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.
Chapter 14: The main points and conclusions of the report.
Chapter 15: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa

Player list
GSK plc
Pfizer Inc.
Sanofi
Walvax Biotechnology Co., Ltd. (Walvax)
Dynavax Technologies Corporation

Types list
Hepatitis B
Rotavirus
Herpes Zoster
Meningococcal B
Others

Application list
Paediatrics
Adults
Veterinary

Table of Content

1 Market Overview
1.1 Recombinant Vaccines Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Recombinant Vaccines Market Size & Forecast
1.4.1 Global Recombinant Vaccines Revenue in Value (2018-2029)
1.4.2 Global Recombinant Vaccines Sales in Volume (2018-2029)
1.4.3 Global Recombinant Vaccines Price (2018-2029)
1.5 Market Drivers, Restraints and Trends
1.5.1 Recombinant Vaccines Market Drivers
1.5.2 Recombinant Vaccines Market Restraints
1.5.3 Recombinant Vaccines Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 GSK plc
2.1.1 Business Overview
2.1.2 GSK plc SWOT Analysis
2.1.3 GSK plc Recombinant Vaccines Products and Service Offered
2.1.4 GSK plc Recombinant Vaccines Sales, Price, Revenue and Gross Margin
2.2 Pfizer Inc.
2.2.1 Business Overview
2.2.2 Pfizer Inc. SWOT Analysis
2.2.3 Pfizer Inc. Recombinant Vaccines Products and Service Offered
2.2.4 Pfizer Inc. Recombinant Vaccines Sales, Price, Revenue and Gross Margin
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Sanofi SWOT Analysis
2.3.3 Sanofi Recombinant Vaccines Products and Service Offered
2.3.4 Sanofi Recombinant Vaccines Sales, Price, Revenue and Gross Margin
2.4 Walvax Biotechnology Co., Ltd. (Walvax)
2.4.1 Business Overview
2.4.2 Walvax Biotechnology Co., Ltd. (Walvax) SWOT Analysis
2.4.3 Walvax Biotechnology Co., Ltd. (Walvax) Recombinant Vaccines Products and Service Offered
2.4.4 Walvax Biotechnology Co., Ltd. (Walvax) Recombinant Vaccines Sales, Price, Revenue and Gross Margin
2.5 Dynavax Technologies Corporation
2.5.1 Business Overview
2.5.2 Dynavax Technologies Corporation SWOT Analysis
2.5.3 Dynavax Technologies Corporation Recombinant Vaccines Products and Service Offered
2.5.4 Dynavax Technologies Corporation Recombinant Vaccines Sales, Price, Revenue and Gross Margin
3 Global Recombinant Vaccines Market Competition, by Manufacturer
3.1 Global Recombinant Vaccines Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant Vaccines Players Market Share in 2022
3.2.2 Top 6 Recombinant Vaccines Players Market Share in 2022
3.2.3 Market Competition Trend
3.3 Recombinant Vaccines Players Head Office, Business Provided
3.4 Recombinant Vaccines Mergers & Acquisitions
3.5 Recombinant Vaccines New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Recombinant Vaccines Revenue in Value by Type (2018-2029)
4.2 Global Recombinant Vaccines Sales in Volume by Type (2018-2029)
4.3 Global Recombinant Vaccines Revenue in Price by Type (2018-2029)
5 Market Segment by Application
5.1 Global Recombinant Vaccines Sales in Volume by Application (2018-2029)
5.2 Global Recombinant Vaccines Revenue by Application (2018-2029)
5.3 Global Recombinant Vaccines Price by Applications (2018-2029)
6 Global Recombinant Vaccines Market Analysis by Regions
6.1 Global Recombinant Vaccines Sales, Revenue and Market Share by Regions
6.1.1 Global Recombinant Vaccines Revenue by Regions (2018-2029)
6.1.2 Global Recombinant Vaccines Sales Volume by Regions (2018-2029)
6.2 North America Recombinant Vaccines Revenue and Growth (2018-2029)
6.3 Europe Recombinant Vaccines Revenue and Growth (2018-2029)
6.4 Asia Pacific Recombinant Vaccines Revenue and Growth (2018-2029)
6.5 South America Recombinant Vaccines Revenue and Growth (2018-2029)
6.6 Middle East and Africa Recombinant Vaccines Revenue and Growth (2018-2029)
7 North America Recombinant Vaccines by Country, by Type, and by Application
7.1 North America Recombinant Vaccines Revenue by Type (2018-2029)
7.2 North America Recombinant Vaccines Revenue by Application (2018-2029)
7.3 North America Recombinant Vaccines Revenue, Sales and Market Share by Countries
7.3.1 North America Recombinant Vaccines Revenue in Value by Country (2018-2029)
7.3.2 North America Recombinant Vaccines Sales by Country (2018-2029)
7.3.3 United States Recombinant Vaccines Revenue and Growth (2018-2029)
7.3.4 Canada Recombinant Vaccines Revenue and Growth (2018-2029)
7.3.5 Mexico Recombinant Vaccines Revenue and Growth (2018-2029)
7.4 North America SWOT Analysis
8 Europe Recombinant Vaccines by Country, by Type, and by Application
8.1 Europe Recombinant Vaccines Revenue by Type (2018-2029)
8.2 Europe Recombinant Vaccines Revenue by Application (2018-2029)
8.3 Europe Recombinant Vaccines Revenue, Sales and Market Share by Countries
8.3.1 Europe Recombinant Vaccines Revenue in Value by Country (2018-2029)
8.3.2 Europe Recombinant Vaccines Sales by Country (2018-2029)
8.3.3 Germany Recombinant Vaccines Revenue and Growth (2018-2029)
8.3.4 France Recombinant Vaccines Revenue and Growth (2018-2029)
8.3.5 United Kingdom Recombinant Vaccines Revenue and Growth (2018-2029)
8.3.6 Russia Recombinant Vaccines Revenue and Growth (2018-2029)
8.3.7 Italy Recombinant Vaccines Revenue and Growth (2018-2029)
8.3.8 Nordic Recombinant Vaccines Revenue and Growth (2018-2029)
8.4 Europe SWOT Analysis
9 Asia Pacific Recombinant Vaccines by Country, by Type, and by Application
9.1 Asia Pacific Recombinant Vaccines Revenue by Type (2018-2029)
9.2 Asia Pacific Recombinant Vaccines Revenue by Application (2018-2029)
9.3 Asia Pacific Recombinant Vaccines Revenue, Sales and Market Share by Countries
9.3.1 Asia Pacific Recombinant Vaccines Revenue in Value by Country (2018-2029)
9.3.2 Asia Pacific Recombinant Vaccines Sales by Country (2018-2029)
9.3.3 China Recombinant Vaccines Revenue and Growth (2018-2029)
9.3.4 Japan Recombinant Vaccines Revenue and Growth (2018-2029)
9.3.5 Korea Recombinant Vaccines Revenue and Growth (2018-2029)
9.3.6 India Recombinant Vaccines Revenue and Growth (2018-2029)
9.3.7 Southeast Asia Recombinant Vaccines Revenue and Growth (2018-2029)
9.3.8 Australia Recombinant Vaccines Revenue and Growth (2018-2029)
9.4 Asia Pacific SWOT Analysis
10 South America Recombinant Vaccines by Country, by Type, and by Application
10.1 South America Recombinant Vaccines Revenue by Type (2018-2029)
10.2 South America Recombinant Vaccines Revenue by Application (2018-2029)
10.3 South America Recombinant Vaccines Revenue, Sales and Market Share by Countries
10.3.1 South America Recombinant Vaccines Revenue in Value by Country (2018-2029)
10.3.2 South America Recombinant Vaccines Sales by Country (2018-2029)
10.3.3 Brazil Recombinant Vaccines Revenue and Growth (2018-2029)
10.3.4 Argentina Recombinant Vaccines Revenue and Growth (2018-2029)
10.4 South America SWOT Analysis
11 Middle East & Africa Recombinant Vaccines by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Vaccines Revenue by Type (2018-2029)
11.2 Middle East & Africa Recombinant Vaccines Revenue by Application (2018-2029)
11.3 Middle East & Africa Recombinant Vaccines Revenue, Sales and Market Share by Countries
11.3.1 Middle East & Africa Recombinant Vaccines Revenue in Value by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant Vaccines Sales by Country (2018-2029)
11.3.3 Turkey Recombinant Vaccines Revenue and Growth (2018-2029)
11.3.4 Egypt Recombinant Vaccines Revenue and Growth (2018-2029)
11.3.5 Saudi Arabia Recombinant Vaccines Revenue and Growth (2018-2029)
11.3.6 UAE Recombinant Vaccines Revenue and Growth (2018-2029)
11.3.7 South Africa Recombinant Vaccines Revenue and Growth (2018-2029)
11.4 Middle East and Africa SWOT Analysis
12 Marketing Channel, Distributors, Traders and Dealers
12.1 Marketing Channel Status
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Vaccines Typical Distributors
12.3 Recombinant Vaccines Typical Customers
12.4 Consumer Behavior Analysis
13 Recombinant Vaccines Manufacturing Cost Analysis
13.1 Recombinant Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Recombinant Vaccines
13.4 Recombinant Vaccines Industrial Chain Analysis
14 Research Findings and Conclusion
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer

List of Tables and Figures

Figure Recombinant Vaccines Picture
Table Product Specifications of Recombinant Vaccines
Figure Global Revenue Market Share of Recombinant Vaccines by Types in 2022
Table Types of Recombinant Vaccines
Figure Recombinant Vaccines Market Share by Applications in 2022
Table Application of Recombinant Vaccines
Figure Global Recombinant Vaccines Revenue in Value (2018-2029)
Figure Global Recombinant Vaccines Sales in Volume (2018-2029)
Table Global Recombinant Vaccines Price (2018-2029)
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table GSK plc Details
Table SWOT Analysis
Table GSK plc Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
Figure GSK plc Revenue Market Share 2018-2023
Table Pfizer Inc. Details
Table SWOT Analysis
Table Pfizer Inc. Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
Figure Pfizer Inc. Revenue Market Share 2018-2023
Table Sanofi Details
Table SWOT Analysis
Table Sanofi Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
Figure Sanofi Revenue Market Share 2018-2023
Table Walvax Biotechnology Co., Ltd. (Walvax) Details
Table SWOT Analysis
Table Walvax Biotechnology Co., Ltd. (Walvax) Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
Figure Walvax Biotechnology Co., Ltd. (Walvax) Revenue Market Share 2018-2023
Table Dynavax Technologies Corporation Details
Table SWOT Analysis
Table Dynavax Technologies Corporation Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
Figure Dynavax Technologies Corporation Revenue Market Share 2018-2023
Table Global Recombinant Vaccines Revenue by Manufacturer (2018-2023)
Figure Global Recombinant Vaccines Revenue Market Share by Manufacturer in 2022
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5) (2018-2023)
Table Recombinant Vaccines Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Global Recombinant Vaccines Revenue in Value by Type (2018-2029)
Table Global Recombinant Vaccines Revenue Share by Type (2018-2029)
Table Global Recombinant Vaccines Sales in Volume by Type (2018-2029)
Table Global Recombinant Vaccines Sales Share by Type (2018-2029)
Table Global Recombinant Vaccines Revenue in Price by Type (2018-2029)
Table Global Recombinant Vaccines Sales in Volume by Application (2018-2029)
Table Global Recombinant Vaccines Sales Share by Application (2018-2029)
Table Global Recombinant Vaccines Revenue by Application (2018-2029)
Table Global Recombinant Vaccines Revenue Share by Application (2018-2029)
Table Global Recombinant Vaccines Price by Applications (2018-2029)
Figure Global Recombinant Vaccines Sales in Volume and Growth (2018-2029)
Figure Global Recombinant Vaccines Revenue and Growth (2018-2029)
Table Global Recombinant Vaccines Revenue by Regions (2018-2029)
Table Global Recombinant Vaccines Revenue Market Share by Regions (2018-2029)
Table Global Recombinant Vaccines Sales Volume by Regions (2018-2029)
Table Global Recombinant Vaccines Sales Volume Market Share by Regions (2018-2029)
Figure North America Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Europe Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Asia Pacific Recombinant Vaccines Revenue and Growth (2018-2029)
Figure South America Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Middle East and Africa Recombinant Vaccines Revenue and Growth (2018-2029)
Table North America Recombinant Vaccines Revenue by Type (2018-2029)
Table North America Recombinant Vaccines Revenue by Application (2018-2029)
Table North America Recombinant Vaccines Revenue by Countries (2018-2029)
Table North America Recombinant Vaccines Revenue Market Share by Countries (2018-2029)
Table North America Recombinant Vaccines Sales in Volume by Countries (2018-2029)
Table North America Recombinant Vaccines Sales Market Share by Countries (2018-2029)
Figure United States Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Canada Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Mexico Recombinant Vaccines Revenue and Growth (2018-2029)
Table SWOT Analysis
Table Europe Recombinant Vaccines Revenue by Type (2018-2029)
Table Europe Recombinant Vaccines Revenue by Application (2018-2029)
Table Europe Recombinant Vaccines Revenue by Countries (2018-2029)
Table Europe Recombinant Vaccines Revenue Market Share by Countries (2018-2029)
Table Europe Recombinant Vaccines Sales in Volume by Countries (2018-2029)
Table Europe Recombinant Vaccines Sales Market Share by Countries (2018-2029)
Figure Germany Recombinant Vaccines Revenue and Growth (2018-2029)
Figure France Recombinant Vaccines Revenue and Growth (2018-2029)
Figure United Kingdom Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Russia Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Italy Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Nordic Recombinant Vaccines Revenue and Growth (2018-2029)
Table SWOT Analysis
Table Asia Pacific Recombinant Vaccines Revenue by Type (2018-2029)
Table Asia Pacific Recombinant Vaccines Revenue by Application (2018-2029)
Table Asia Pacific Recombinant Vaccines Revenue by Countries (2018-2029)
Table Asia Pacific Recombinant Vaccines Revenue Market Share by Countries (2018-2029)
Table Asia Pacific Recombinant Vaccines Sales in Volume by Countries (2018-2029)
Table Asia Pacific Recombinant Vaccines Sales Market Share by Countries (2018-2029)
Figure China Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Japan Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Korea Recombinant Vaccines Revenue and Growth (2018-2029)
Figure India Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Southeast Asia Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Australia Recombinant Vaccines Revenue and Growth (2018-2029)
Table SWOT Analysis
Table South America Recombinant Vaccines Revenue by Type (2018-2029)
Table South America Recombinant Vaccines Revenue by Application (2018-2029)
Table South America Recombinant Vaccines Revenue by Countries (2018-2029)
Table South America Recombinant Vaccines Revenue Market Share by Countries (2018-2029)
Table South America Recombinant Vaccines Sales in Volume by Countries (2018-2029)
Table South America Recombinant Vaccines Sales Market Share by Countries (2018-2029)
Figure Brazil Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Argentina Recombinant Vaccines Revenue and Growth (2018-2029)
Table SWOT Analysis
Table Middle East & Africa Recombinant Vaccines Revenue by Type (2018-2029)
Table Middle East & Africa Recombinant Vaccines Revenue by Application (2018-2029)
Table Middle East & Africa Recombinant Vaccines Revenue by Countries (2018-2029)
Table Middle East & Africa Recombinant Vaccines Revenue Market Share by Countries (2018-2029)
Table Middle East & Africa Recombinant Vaccines Sales in Volume by Countries (2018-2029)
Table Middle East & Africa Recombinant Vaccines Sales Market Share by Countries (2018-2029)
Figure Turkey Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Egypt Recombinant Vaccines Revenue and Growth (2018-2029)
Figure Saudi Arabia Recombinant Vaccines Revenue and Growth (2018-2029)
Figure UAE Recombinant Vaccines Revenue and Growth (2018-2029)
Figure South Africa Recombinant Vaccines Revenue and Growth (2018-2029)
Table SWOT Analysis
Table Distributors of Recombinant Vaccines with Contact Information
Table Major Customers of Recombinant Vaccines with Contact Information
Table Consumer Behavior Analysis
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Table Raw Materials Analysis
Table Labor Cost Analysis
Table Manufacturing Expenses Analysis
Table Manufacturing Process Analysis of Recombinant VaccinesAnalysis
Figure Recombinant Vaccines Industrial Chain Analysis
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report